about
Morphologic features of extrahepatic manifestations of hepatitis C virus infectionHepatitis C and insulin action: An intimate relationshipRisk Factors for the Development of Hepatocellular Carcinoma in ThailandDiabetes-induced hepatic pathogenic damage, inflammation, oxidative stress, and insulin resistance was exacerbated in zinc deficient mouse modelWhat are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis.Characteristics of oral abnormalities in liver transplant candidates.Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.Predicting the probable outcome of treatment in HCV patients.Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses.The extracellular matrix and insulin resistance.Association between hepatitis B virus infection and diabetes mellitus: A meta-analysis.Hepatitis C virus infection and nonalcoholic steatohepatitisGlucose abnormalities in Asian patients with chronic hepatitis CAn Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?Vaccinating Adult Patients with Cirrhosis: Trends over a Decade in the United States.Featured Article: Oxidative stress status and liver tissue defenses in diabetic rats during intensive subcutaneous insulin therapy.Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and managementSialadenosis in patients with advanced liver disease.Role of viral and host factors in interferon based therapy of hepatitis C virus infectionGlycated Hemoglobin Levels in Patients with Decompensated Cirrhosis.Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma.Persicarin isolated from Oenanthe javanica protects against diabetes-induced oxidative stress and inflammation in the liver of streptozotocin-induced type 1 diabetic mice.Metabolic alterations and chronic hepatitis C: treatment strategies.Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.Diabetes mellitus is associated with the presence of metastatic spread at disease presentation in hepatocellular carcinoma.Nutrition assessment and management in advanced liver disease.Nonalcoholic fatty liver disease: current issues and novel treatment approaches.Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.Extrahepatic manifestations in chronic hepatitis C virus carriers.Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?Lipotoxicity in Obesity: Benefit of Olive Oil.Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats.Lipid metabolism and inflammation modulated by Vitamin D in liver of diabetic rats.Hypolipidemic, Hepatoprotective and Renoprotective Effects of Cydonia Oblonga Mill. Fruit in Streptozotocin-Induced Diabetic Rats.Prolonged inhibition of glycogen phosphorylase in livers of Zucker Diabetic Fatty rats models human glycogen storage diseases.Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
P2860
Q21284981-93199942-406F-4E03-AA7E-C40FE61A1397Q26775000-F970C44D-F414-4DEB-B257-AB74284F4B0EQ26775650-7F28E1C8-2174-4D84-BB19-0B1D1097F0E5Q28484324-C330C0E6-9BFF-42B9-954D-6F5B2ADB24B8Q30361645-983058E3-7994-4A9C-BD44-0B167C2780B7Q33735381-A8DAEE82-720B-4F43-B3D8-514B92BEC163Q33871682-C1FDB345-B978-4AF6-B998-AB0D90EED2F7Q34008552-2D6918C2-347A-44A2-BB6E-D53F72CB86E7Q34409039-8969D53A-109F-4658-A301-33BE01D7BB11Q35073701-BF211AEB-2A86-4141-A51F-B3BB75B36FF0Q35812133-9F7B6F9C-67F3-494E-AFB0-48A5285CC687Q35870482-4730ABF7-0FBD-4EFC-89A3-9336C6561504Q36179898-E1A1E312-23B5-444E-8F82-35189AE3DA62Q36277992-DAF7F761-4EF3-4D46-8EB6-3470C870DBFEQ36328050-15117C87-629C-4593-990E-996A2DD06813Q36602895-9591A642-C43D-407E-ADD6-4432885A0D40Q36901395-6F92BF6A-CCAE-4798-BD29-550FF1567E7BQ37071494-0D0603DC-B7A1-4857-8D6A-20C780F5EAB8Q37122216-7EEABD2E-B4FD-4C44-978F-06389B314B35Q37274279-A888DC0C-A464-460D-B43E-1F20C4418506Q37362240-AA2422E0-361A-4382-BB1C-8ACD22AF134CQ37416442-55A543B5-8E08-4F3F-AC46-A81FCA655557Q37417134-C5D891D7-43E0-43BF-9E65-6846BFEE9256Q37734583-1BC5F572-88B8-44C5-B51D-58D80E5F016EQ37924816-B11319BD-27B7-49AD-8879-A2AB76909C25Q37932057-D57C2A62-B629-42E5-A868-DB501D2D527EQ37980432-02E1A16B-8A8F-4583-A567-5F8B73452CE2Q38052626-438E15F7-C08F-4D9A-BA9B-BAF64FF0B985Q38074112-10C73224-FA9B-49B7-ADED-1ABC113A2326Q38074898-84E0E299-8E92-45C9-8A30-47C6EFEF861AQ38313236-F9766F44-3C48-43A9-BED7-6FF3D54B0DD8Q38388423-60D8E007-C60D-4CF8-97E1-6A3A51B0889DQ38606170-807D86EF-CA7A-47DD-BB99-7572AD66E514Q39036315-539BBCFB-A985-4273-A042-1EDEC2AB68ECQ39353777-DC08F719-EC6F-4434-A213-A6FD8171BB2CQ39390726-DB68E978-0F8A-4006-A2FB-6424D4F49EC5Q39867039-D6C7E53F-4599-4FEC-874D-217FDF557886Q41813630-E7B90AB2-BD17-4C1F-A9B7-6F5E4DEF311CQ43136756-54DD48A7-273E-480C-B406-5445B6653418Q43476077-EFD20996-D17B-4848-A762-050CD9F5ACC3
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Liver disease in patients with diabetes mellitus.
@ast
Liver disease in patients with diabetes mellitus.
@en
type
label
Liver disease in patients with diabetes mellitus.
@ast
Liver disease in patients with diabetes mellitus.
@en
prefLabel
Liver disease in patients with diabetes mellitus.
@ast
Liver disease in patients with diabetes mellitus.
@en
P1476
Liver disease in patients with diabetes mellitus.
@en
P2093
Stephen A Harrison
P356
10.1097/01.MCG.0000190774.91875.D2
P577
2006-01-01T00:00:00Z